Published in Circulation on August 07, 2001
Functional pace-mapping responses for identification of targets for catheter ablation of scar-mediated ventricular tachycardia. Circ Arrhythm Electrophysiol (2012) 1.89
Freedom from recurrent ventricular tachycardia after catheter ablation is associated with improved survival in patients with structural heart disease: An International VT Ablation Center Collaborative Group study. Heart Rhythm (2015) 1.70
Percutaneous left ventricular assist devices in ventricular tachycardia ablation: multicenter experience. Circ Arrhythm Electrophysiol (2014) 1.64
Magnetic resonance-based anatomical analysis of scar-related ventricular tachycardia: implications for catheter ablation. Circ Res (2007) 1.58
[Guidelines for catheter ablation]. Clin Res Cardiol (2007) 1.02
Ventricular tachycardia and sudden cardiac death. Mayo Clin Proc (2009) 1.01
Efficacy and safety of ventricular tachycardia ablation with mechanical circulatory support compared with substrate-based ablation techniques. Europace (2011) 1.00
Assessing epicardial substrate using intracardiac echocardiography during VT ablation. Circ Arrhythm Electrophysiol (2011) 0.93
Novel mapping techniques for cardiac electrophysiology. Heart (2002) 0.88
Transapical access for catheter ablation of left ventricular tachycardia in a patient with mechanical aortic and mitral valve prosthesis. Clin Res Cardiol (2014) 0.87
Successful catheter ablation of persistent electrical storm late post myocardial infarction by targeting purkinje arborization triggers. Indian Pacing Electrophysiol J (2008) 0.86
Is single-view fluoroscopy sufficient in guiding cardiac ablation procedures? Int J Biomed Imaging (2010) 0.85
Optimal ablation strategies for different types of ventricular tachycardias. Nat Rev Cardiol (2012) 0.85
Mapping and ablation of ventricular arrhythmias with magnetic navigation: comparison between 4- and 8-mm catheter tips. J Interv Card Electrophysiol (2009) 0.85
Acute failure of catheter ablation for ventricular tachycardia due to structural heart disease: causes and significance. J Am Heart Assoc (2013) 0.84
Catheter-ablation of ventricular tachycardia in patients with coronary artery disease: influence of the endocardial substrate size on clinical outcome. Clin Res Cardiol (2007) 0.83
Long-term outcomes of catheter ablation of ventricular tachycardia in patients with structural heart disease. J Arrhythm (2014) 0.83
Cardiac ablation catheter guidance by means of a single equivalent moving dipole inverse algorithm. Pacing Clin Electrophysiol (2013) 0.83
Substrate-modification using electroanatomical mapping in sinus rhythm to treat ventricular tachycardia in patients with ischemic cardiomyopathy. Z Kardiol (2005) 0.82
Relationship of late potentials to the ventricular tachycardia circuit defined by entrainment. J Interv Card Electrophysiol (2009) 0.82
Prophylactic catheter ablation of ventricular tachycardia before cardioverter-defibrillator implantation in patients with non-ischemic cardiomyopathy: Clinical outcomes after a single endocardial ablation. J Arrhythm (2015) 0.82
Ventricular mapping during atrial and right ventricular pacing: relation of electrogram parameters to ventricular tachycardia reentry circuits after myocardial infarction. J Interv Card Electrophysiol (2004) 0.80
Electrical homogenization of ventricular scar by application of collagenase: a novel strategy for arrhythmia therapy. Circ Arrhythm Electrophysiol (2013) 0.79
c-Src kinase inhibition reduces arrhythmia inducibility and connexin43 dysregulation after myocardial infarction. J Am Coll Cardiol (2014) 0.78
Role of catheter ablation of ventricular tachycardia associated with structural heart disease. World J Cardiol (2011) 0.78
Spatiotemporal electrophysiological changes in a murine ablation model. Europace (2011) 0.77
Distribution of abnormal potentials in chronic myocardial infarction using a real time magnetic resonance guided electrophysiology system. J Cardiovasc Magn Reson (2015) 0.77
Relationship between sinus rhythm late activation zones and critical sites for scar-related ventricular tachycardia: systematic analysis of isochronal late activation mapping. Circ Arrhythm Electrophysiol (2015) 0.77
Unmappable ventricular tachycardia after an old myocardial infarction. Long-term results of substrate modification in patients with an implantable cardioverter defibrillator. J Interv Card Electrophysiol (2011) 0.76
Non-contact mapping in the treatment of ventricular tachycardia after myocardial infarction. J Interv Card Electrophysiol (2007) 0.76
Ventricular Tachycardia Ablation - The Right Approach for the Right Patient. Arrhythm Electrophysiol Rev (2014) 0.75
Contemporary Mapping Techniques of Complex Cardiac Arrhythmias - Identifying and Modifying the Arrhythmogenic Substrate. Arrhythm Electrophysiol Rev (2015) 0.75
Improving our understanding of epicardial ventricular tachycardia in nonischemic cardiomyopathy. J Am Coll Cardiol (2009) 0.75
Integration of MR images with electroanatomical maps: feasibility and utility in guiding left ventricular substrate mapping. J Interv Card Electrophysiol (2010) 0.75
Mapping for the target sites of ablation in post-infarction ventricular tachycardia--is sinus rhythm sufficient? Indian Pacing Electrophysiol J (2009) 0.75
Predictors of success in ablation of scar-related ventricular tachycardia. Clin Med Insights Cardiol (2013) 0.75
Ventricular tachycardia ablation and substrate modification in ICD patients with electrical storm. J Biomed Res (2015) 0.75
Cardiac Sympathetic Innervation Via the Middle Cervical and Stellate Ganglia and Anti-Arrhythmic Mechanism of Bilateral Stellectomy. Am J Physiol Heart Circ Physiol (2016) 0.75
Incessant ventricular tachycardia acutely controlled with off-pump coronary artery bypass surgery and aneurysmal plication. J Tehran Heart Cent (2010) 0.75
Radiofrequency ablation of drug refractory ventricular tachycardia related to cocaine use: a feasibility, safety, and efficacy study. J Cardiovasc Electrophysiol (2014) 0.75
Ripple mapping: making electroanatomic mapping user-friendly. Heart Rhythm (2009) 0.75
Contrast-Enhanced C-arm Computed Tomography Imaging of Myocardial Infarction in the Interventional Suite. Invest Radiol (2015) 0.75
[Three-dimensional mapping systems]. Herzschrittmacherther Elektrophysiol (2012) 0.75
Clinical results with catheter ablation: AV junction, atrial fibrillation and ventricular tachycardia. J Interv Card Electrophysiol (2003) 0.75
Evaluation of the use of unipolar voltage amplitudes for detection of myocardial scar assessed by cardiac magnetic resonance imaging in heart failure patients. PLoS One (2017) 0.75
Successful bipolar ablation for ventricular tachycardia with potential substrate identification by pre-procedural cardiac magnetic resonance imaging. Int Med Case Rep J (2017) 0.75
Non-randomised comparison of acute and long-term outcomes of robotic versus manual ventricular tachycardia ablation in a single centre ischemic cohort. J Interv Card Electrophysiol (2015) 0.75
[Catheter ablation for the treatment of electrical storm: methods and outcome]. Herzschrittmacherther Elektrophysiol (2014) 0.75
[3-D mapping and ablation of recurrent ventricular tachycardia in patients with ischemic cardiomyopathy]. Herzschrittmacherther Elektrophysiol (2017) 0.75
The transcriptional landscape of the mammalian genome. Science (2005) 37.63
Antisense transcription in the mammalian transcriptome. Science (2005) 15.69
Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci U S A (1991) 8.04
Peroral endoscopic myotomy (POEM) for esophageal achalasia. Endoscopy (2010) 7.10
Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases. Proc Natl Acad Sci U S A (1994) 6.96
Peptidyl-prolyl cis-trans isomerase is the cyclosporin A-binding protein cyclophilin. Nature (1989) 5.86
A standard reference frame for the description of nucleic acid base-pair geometry. J Mol Biol (2001) 4.29
Clinically mild encephalitis/encephalopathy with a reversible splenial lesion. Neurology (2004) 4.24
The PILATUS 1M detector. J Synchrotron Radiat (2006) 4.16
Cross-contamination potential with dental equipment. Lancet (1992) 3.55
Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy. Cancer (2000) 3.46
A new form of amyloid protein associated with chronic hemodialysis was identified as beta 2-microglobulin. Biochem Biophys Res Commun (1985) 3.40
Recalls and safety alerts involving pacemakers and implantable cardioverter-defibrillator generators. JAMA (2001) 3.38
Identification of reentry circuit sites during catheter mapping and radiofrequency ablation of ventricular tachycardia late after myocardial infarction. Circulation (1993) 3.26
Bacterial genomic reorganization upon DNA replication. Science (2001) 3.25
Alymphoplasia is caused by a point mutation in the mouse gene encoding Nf-kappa b-inducing kinase. Nat Genet (1999) 3.17
Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92. Oncogene (2007) 3.11
A novel transgenic technique that allows specific marking of the neural crest cell lineage in mice. Dev Biol (1999) 3.11
Development of an MRI-compatible needle insertion manipulator for stereotactic neurosurgery. J Image Guid Surg (1995) 3.07
Visualization of neurogenesis in the central nervous system using nestin promoter-GFP transgenic mice. Neuroreport (2000) 3.04
Increased insulin sensitivity and hypoglycaemia in mice lacking the p85 alpha subunit of phosphoinositide 3-kinase. Nat Genet (1999) 2.81
Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis. Nature (2002) 2.71
A novel mode of DNA recognition by a beta-sheet revealed by the solution structure of the GCC-box binding domain in complex with DNA. EMBO J (1998) 2.48
Anatomic correction of the syndrome of prolapsing right coronary aortic cusp, dilatation of the sinus of Valsalva, and ventricular septal defect. J Thorac Cardiovasc Surg (1997) 2.40
Spectrodensitometric determination of trichothecene mycotoxins with 4-(p-nitrobenzyl)pyridine on silica gel thin-layer chromatograms. J Chromatogr (1979) 2.38
Modulation of the Ca2 permeable cation channel TRPV4 by cytochrome P450 epoxygenases in vascular endothelium. Circ Res (2005) 2.38
Mutually exclusive expression of odorant receptor transgenes. Nat Neurosci (2000) 2.36
Truncated CBP protein leads to classical Rubinstein-Taybi syndrome phenotypes in mice: implications for a dominant-negative mechanism. Hum Mol Genet (1999) 2.32
Physiological role of silent receptors of atrial natriuretic factor. Science (1987) 2.31
Long-term efficacy of amiodarone for the maintenance of normal sinus rhythm in patients with refractory atrial fibrillation or flutter. Am J Cardiol (1995) 2.31
Exploring postinfarction reentrant ventricular tachycardia with entrainment mapping. J Am Coll Cardiol (1997) 2.27
Altered cochlear fibrocytes in a mouse model of DFN3 nonsyndromic deafness. Science (1999) 2.25
Induction of microRNAs, mir-155, mir-222, mir-424 and mir-503, promotes monocytic differentiation through combinatorial regulation. Leukemia (2009) 2.24
'SPKK' motifs prefer to bind to DNA at A/T-rich sites. EMBO J (1989) 2.24
Biophysical characteristics of HIMAC clinical irradiation system for heavy-ion radiation therapy. Int J Radiat Oncol Biol Phys (1999) 2.19
Protease nexin-II, a potent antichymotrypsin, shows identity to amyloid beta-protein precursor. Nature (1989) 2.17
Activation of the Keap1/Nrf2 pathway for neuroprotection by electrophilic [correction of electrophillic] phase II inducers. Proc Natl Acad Sci U S A (2006) 2.15
Low-dose amiodarone for atrial fibrillation: time for a prospective study? Ann Intern Med (1992) 2.14
Atrial fibrillation after cardiac surgery. Ann Intern Med (2001) 2.10
Proline-directed and non-proline-directed phosphorylation of PHF-tau. J Biol Chem (1995) 2.09
The PTEN/MMAC1/TEP tumor suppressor gene decreases cell growth and induces apoptosis and anoikis in breast cancer cells. Oncogene (1999) 2.07
LST-2, a human liver-specific organic anion transporter, determines methotrexate sensitivity in gastrointestinal cancers. Gastroenterology (2001) 2.02
Prenatal DNA diagnosis of a single-gene disorder from maternal plasma. Lancet (2000) 2.01
Analysis of platelet abnormalities in uremia with and without Glanzmann's thrombasthenia. Nephron (1994) 2.00
Solitary fibrous tumour: significance of p53 and CD34 immunoreactivity in its malignant transformation. Histopathology (1998) 2.00
Evidence that errors made by DNA polymerase alpha are corrected by DNA polymerase delta. Curr Biol (2006) 1.98
DNA binding of PhoB and its interaction with RNA polymerase. J Mol Biol (1996) 1.97
Sleep disturbances in clinic patients with functional bowel disorders. Am J Gastroenterol (2000) 1.96
Relation between use of health check ups starting in middle age and demand for inpatient care by elderly people in Japan. BMJ (1991) 1.96
Predicting prescribing costs in general practice using practice demography. Pharmacoepidemiol Drug Saf (1997) 1.93
A novel protein phosphatase-1 inhibitory protein potentiated by protein kinase C. Isolation from porcine aorta media and characterization. J Biochem (1995) 1.92
Patterns of beat-to-beat heart rate variability in advanced heart failure. Am Heart J (1992) 1.91
Protein sequence and mass spectrometric analyses of tau in the Alzheimer's disease brain. J Biol Chem (1992) 1.89
Prokaryotic DNA polymerase I: evolution, structure, and "base flipping" mechanism for nucleotide selection. J Mol Biol (2001) 1.88
Identification of a novel gene family encoding human liver-specific organic anion transporter LST-1. J Biol Chem (1999) 1.87
NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxel. Br J Cancer (2005) 1.87
ONO-5046, a novel inhibitor of human neutrophil elastase. Biochem Biophys Res Commun (1991) 1.85
Entrainment mapping and radiofrequency catheter ablation of ventricular tachycardia in right ventricular dysplasia. J Am Coll Cardiol (1998) 1.85
Promotion of parallel DNA quadruplexes by a yeast telomere binding protein: a circular dichroism study. Proc Natl Acad Sci U S A (1994) 1.83
Scavenging effects of tea catechins and their derivatives on 1,1-diphenyl-2-picrylhydrazyl radical. Free Radic Biol Med (1996) 1.82
Transposable element in fish. Nature (1996) 1.80
Aneurysms at nonbranching sites in the surpaclinoid portion of the internal carotid artery: internal carotid artery trunk aneurysms. Neurosurgery (2000) 1.80
Dioxin binding activities of polymorphic forms of mouse and human arylhydrocarbon receptors. J Biol Chem (1994) 1.78
The 5' upstream region of mPer1 gene contains two promoters and is responsible for circadian oscillation. Curr Biol (2000) 1.74
Site-directed mutagenesis of the Klebsiella pneumoniae nifL and nifH promoters and in vivo analysis of promoter activity. Nucleic Acids Res (1985) 1.73
Mapping and radiofrequency catheter ablation of the three types of sustained monomorphic ventricular tachycardia in nonischemic heart disease. J Cardiovasc Electrophysiol (2000) 1.73
Biochemical characterization of the Wilson disease protein and functional expression in the yeast Saccharomyces cerevisiae. J Biol Chem (1997) 1.72
An optical spectrum of the afterglow of a gamma-ray burst at a redshift of z = 6.295. Nature (2006) 1.70
Ablation of cerebellar Golgi cells disrupts synaptic integration involving GABA inhibition and NMDA receptor activation in motor coordination. Cell (1998) 1.69
Increased expression of S100A4, a metastasis-associated gene, in human colorectal adenocarcinomas. Clin Cancer Res (1997) 1.68
Clear cell carcinoma of the ovary: a retrospective multicentre experience of 254 patients with complete surgical staging. Br J Cancer (2006) 1.67
Archaeal adaptation to higher temperatures revealed by genomic sequence of Thermoplasma volcanium. Proc Natl Acad Sci U S A (2000) 1.67
Hypoxic brain damage: cortical laminar necrosis and delayed changes in white matter at sequential MR imaging. Radiology (1993) 1.65
Development of the polymer micelle carrier system for doxorubicin. J Control Release (2001) 1.64
Molecular cloning of a novel form (two-repeat) protein related to voltage-gated sodium and calcium channels. Biochem Biophys Res Commun (2000) 1.64
Pneumomediastinum in dermatomyositis: association with cutaneous vasculopathy. Ann Rheum Dis (2000) 1.63
Untreated ocular hypertension. A long-term prospective study. Arch Ophthalmol (1977) 1.62
Palmar fasciitis and polyarthritis associated with gastric carcinoma: complete resolution after total gastrectomy. Intern Med (2000) 1.62
Apoptosis is a major mode of cell death caused by ischaemia and ischaemia/reperfusion injury to the rat intestinal epithelium. Gut (1998) 1.61
Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients. Circulation (1991) 1.61
Diverse mechanisms of unexpected cardiac arrest in advanced heart failure. Circulation (1989) 1.61
Role of specific determinants in mannan of Candida albicans serotype A in adherence to human buccal epithelial cells. Infect Immun (1992) 1.60
A novel, high endothelial venule-specific sulfotransferase expresses 6-sulfo sialyl Lewis(x), an L-selectin ligand displayed by CD34. Immunity (1999) 1.59
Biochemical characterization and intracellular localization of the Menkes disease protein. Proc Natl Acad Sci U S A (1996) 1.59
Silica accumulation in long-lived leaves of Sasa veitchii (Carrière) Rehder (Poaceae-Bambusoideae). Ann Bot (2002) 1.59
Leukocyte adherence to venular endothelium during ischemia-reperfusion. Am J Physiol (1989) 1.58
Chemosensitivity and p53-Bax pathway-mediated apoptosis in patients with uterine cervical cancer. Ann Oncol (2003) 1.58
High expression of macrophage migration inhibitory factor in human melanoma cells and its role in tumor cell growth and angiogenesis. Biochem Biophys Res Commun (1999) 1.58
RNAs extracted from herpes simplex virus 1 virions: apparent selectivity of viral but not cellular RNAs packaged in virions. J Virol (2001) 1.57
Overexpression of ERK, an EPH family receptor protein tyrosine kinase, in various human tumors. Cancer Res (1994) 1.55
Analysis and purification of toxic peptides from cyanobacteria by reversed-phase high-performance liquid chromatography. J Chromatogr (1988) 1.55
[Studies on antispetics for foodstuff. LXXI. Studies on orsellinic acid ester, beta-orcinolcarboxylic acid ester and olivetonide as a preservative for sake]. Yakugaku Zasshi (1970) 1.54
Radiation risk to low fluences of alpha particles may be greater than we thought. Proc Natl Acad Sci U S A (2001) 1.53
Daytime sleepiness and other sleep disorders in Parkinson's disease. Neurology (2001) 1.52
Toxins contained in Microcystis species of cyanobacteria (blue-green algae). Toxicon (1988) 1.52
Two distinct forms of peptidylprolyl-cis-trans-isomerase are expressed separately in periplasmic and cytoplasmic compartments of Escherichia coli cells. Biochemistry (1991) 1.50
Differential roles of interleukin 15 mRNA isoforms generated by alternative splicing in immune responses in vivo. J Exp Med (2000) 1.50